a Institute of Dermatology , Anhui Medical University , Hefei , Anhui , China.
b Hospital of Anhui Medical University, Anhui Medical University , Hefei , Anhui , China.
J Immunotoxicol. 2018 Dec;15(1):126-136. doi: 10.1080/1547691X.2018.1532974.
Trichloroethylene (TCE) is known to induce skin disorders and multi-system dysfunction, but the mechanism of this multi-organ injury is not entirely clear. It was shown in a previous study that levels of pivotal end-products of the kallikrein-kinin system (KKS), i.e. bradykinin (BK) and BK receptors B1R/B2R, in the kidneys were increased by TCE exposure. Unfortunately, how BK and its receptors acted in the etiology of the induced renal injury is not clear. Thus, this study explored any correlation between BK receptors and immune renal injury in TCE-sensitized mice by blocking the BK receptors B1R/B2R. BALB/c mice were sensitized (via skin) by TCE, with or without pre-treatment with a B1R or B2R antagonist. Renal lesions, increased expressions of B1R, B2R, Kim-1, Lipocalin-2, and NF-κB p65 subunit on tubular epithelial cells were all observed in TCE-sensitized mice. Serum levels of creatinine (Cr), microglobulin α1 and β2, along with mRNA levels for inflammatory cytokines and NF- κB p65 in kidneys, were all increased by 72 h after a final challenge. Highly selective antagonist pre-treatment blocked B2R and significantly attenuated TCE-induced changes. Blocking B1R or B2R attenuated release of pro-inflammatory cytokines and activation of NF-κB signaling pathway (as reflected in lower up-regulation of pIκB and nuclear NF-κB p65 subunit, and down-regulation of IκB in the kidneys. These results provided evidence that TCE-sensitization caused KKS activation and enhanced the expression of B1R and B2R on tubular epithelial cells. This, in turn, accelerated NF-κB signaling pathway activation and amplified inflammatory cytokine release, which all likely contributed to TCE-induced immune renal injury.
三氯乙烯(TCE)已知可引起皮肤疾病和多系统功能障碍,但这种多器官损伤的机制尚不完全清楚。先前的一项研究表明,TCE 暴露可使激肽释放酶-激肽系统(KKS)的关键终产物水平升高,即缓激肽(BK)和 BK 受体 B1R/B2R。不幸的是,BK 及其受体在诱导性肾损伤中的作用尚不清楚。因此,本研究通过阻断 BK 受体 B1R/B2R,探讨了 TCE 致敏小鼠中 BK 受体与免疫性肾损伤之间的任何相关性。BALB/c 小鼠通过 TCE (经皮)致敏,或在致敏前用 B1R 或 B2R 拮抗剂预处理。在 TCE 致敏的小鼠中观察到肾损伤、B1R、B2R、Kim-1、脂联素-2 和 NF-κB p65 亚基在肾小管上皮细胞中的表达增加。在最后一次挑战后 72 小时,血清肌酐(Cr)、微球蛋白α1 和β2 水平以及肾脏中炎症细胞因子和 NF-κB p65 的 mRNA 水平均升高。高选择性拮抗剂预处理阻断 B2R,并显著减轻 TCE 诱导的变化。阻断 B1R 或 B2R 可减轻促炎细胞因子的释放和 NF-κB 信号通路的激活(反映为 pIκB 和核 NF-κB p65 亚基的下调以及肾脏中 IκB 的下调)。这些结果提供了证据表明,TCE 致敏导致 KKS 激活,并增强了肾小管上皮细胞上 B1R 和 B2R 的表达。这反过来又加速了 NF-κB 信号通路的激活,并放大了炎症细胞因子的释放,这可能都有助于 TCE 引起的免疫性肾损伤。